<DOC>
	<DOCNO>NCT00763568</DOCNO>
	<brief_summary>The purpose study determine take nitazoxanide alone 4 week follow 36 week nitazoxanide plus peginterferon superior peginterferon plus ribavirin ( standard care ) 48 week .</brief_summary>
	<brief_title>4-Week Lead-In With Nitazoxanide Followed 36 Weeks Nitazoxanide Peginterferon Alfa-2a Chronic Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Nitazoxanide</mesh_term>
	<criteria>Chronic hepatitis C Previously fail respond least 12 week peginterferon plus ribavirin combination therapy . Unable take oral medication . Females either pregnant , breastfeed use birth control . Males whose female partner pregnant plan become pregnant . Other cause liver disease ( example , autoimmune hepatitis , decompensated liver disease ) . Patients HIV , HAV , HBV HDV . Patients history alcoholism alcohol consumption 40 gram per day . Patients hemoglobinopathy ( example , thalassemia major , sicklecell anemia ) . History hypersensitivity intolerance nitazoxanide peginterferon .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Chronic hepatitis C</keyword>
	<keyword>Viral hepatitis</keyword>
</DOC>